PolyPid

Market Cap

$97M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$4.50+$0.15 (+3.45%)

Jun 5, 2026

52W High $5.0752W Low $3.15

Company Details

PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead pro...

CEO

—

IPO Date

Jun 26, 2020

Website

www.polypid.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$34M

EPS (Diluted)

Free Cash Flow

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 12, 2026

PENDING

Q1 2026

May 13, 2026

FY 2025

Feb 25, 2026

Q4 2025

Feb 25, 2026

Q3 2025

Nov 12, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee